Sichuan Kelun Pharmaceutical Hits Day Low Amid Price Pressure at CNY 44.49

Sichuan Kelun Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 4.84% and reaching an intraday low of CNY 44.49. This performance contrasts with the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, Sichuan Kelun's stock has decreased by 0.53%, while the broader market index fell by 0.56%. In the past month, the stock has declined by 5.26%, compared to a 1.06% gain in the Shanghai Composite. However, the company has shown resilience over the longer term, with a year-to-date performance of 52.88%, significantly outperforming the index's decline of 1.6%. Despite these longer-term gains, recent financial metrics indicate challenges. The company has reported negative results for the last six consecutive quarters, with operating cash flow at its lowest point of CNY 2,608.1 million and a net profit decline of 32.93% over the past nine months. The return on capital employed (ROCE) is also at a low of 6.58%. These factors contribute to the stock's current performance and market position within the pharmaceuticals and biotechnology industry.